Promoter methylation of argininosuccinate synthetase-1 sensitises lymphomas to arginine deiminase treatment, autophagy and caspase-dependent apoptosis

[1]  Hui-Kuan Lin,et al.  Activation of Ras/PI3K/ERK pathway induces c-Myc stabilization to upregulate argininosuccinate synthetase, leading to arginine deiminase resistance in melanoma cells. , 2012, Cancer research.

[2]  I. Sheen,et al.  A randomised phase II study of pegylated arginine deiminase (ADI-PEG 20) in Asian advanced hepatocellular carcinoma patients , 2010, British Journal of Cancer.

[3]  B. Delage,et al.  Arginine deprivation and argininosuccinate synthetase expression in the treatment of cancer , 2010, International journal of cancer.

[4]  F. Izzo,et al.  Phase II study of pegylated arginine deiminase for nonresectable and metastatic hepatocellular carcinoma. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  E. Gottlieb,et al.  Targeting metabolic transformation for cancer therapy , 2010, Nature Reviews Cancer.

[6]  S. Hirohashi,et al.  Reduced Argininosuccinate Synthetase Is a Predictive Biomarker for the Development of Pulmonary Metastasis in Patients with Osteosarcoma , 2010, Molecular Cancer Therapeutics.

[7]  N. Savaraj,et al.  Resistance to arginine deiminase treatment in melanoma cells is associated with induced argininosuccinate synthetase expression involving c-Myc/HIF-1α/Sp4 , 2009, Molecular Cancer Therapeutics.

[8]  L. Nicholson,et al.  Epigenetic silencing of argininosuccinate synthetase confers resistance to platinum‐induced cell death but collateral sensitivity to arginine auxotrophy in ovarian cancer , 2009, International journal of cancer.

[9]  M. Munder,et al.  l-Arginine deprivation impairs Leishmania major-specific T-cell responses , 2009, European journal of immunology.

[10]  Randy D. Gascoyne,et al.  Array-based DNA methylation profiling in follicular lymphoma , 2009, Leukemia.

[11]  P. Meltzer,et al.  Large-scale profiling of archival lymph nodes reveals pervasive remodeling of the follicular lymphoma methylome. , 2009, Cancer research.

[12]  Frank Y. S. Chuang,et al.  Arginine deiminase as a novel therapy for prostate cancer induces autophagy and caspase-independent apoptosis. , 2009, Cancer research.

[13]  M. Wangpaichitr,et al.  Arginine deprivation as a targeted therapy for cancer. , 2008, Current pharmaceutical design.

[14]  G. Evan,et al.  Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma. , 2007, The Journal of clinical investigation.

[15]  D. Fennell,et al.  In vivo Loss of Expression of Argininosuccinate Synthetase in Malignant Pleural Mesothelioma Is a Biomarker for Susceptibility to Arginine Depletion , 2006, Clinical Cancer Research.

[16]  F. Izzo,et al.  Pegylated arginine deiminase treatment of patients with metastatic melanoma: results from phase I and II studies. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  V. Bronte,et al.  Regulation of immune responses by L-arginine metabolism , 2005, Nature Reviews Immunology.

[18]  D. Wheatley,et al.  Arginine deiminase enhances dexamethasone‐induced cytotoxicity in human T‐lymphoblastic leukemia CCRF‐CEM cells , 2004, International journal of cancer.

[19]  Guoyao Wu,et al.  Citrulline Can Preserve Proliferation and Prevent the Loss of CD3 ζ Chain Under Conditions of Low Arginine. , 2004, JPEN. Journal of parenteral and enteral nutrition.

[20]  J. Brayer,et al.  Arginase I Production in the Tumor Microenvironment by Mature Myeloid Cells Inhibits T-Cell Receptor Expression and Antigen-Specific T-Cell Responses , 2004, Cancer Research.

[21]  F. Izzo,et al.  Pegylated arginine deiminase treatment of patients with unresectable hepatocellular carcinoma: results from phase I/II studies. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  A. Burton,et al.  The Effects of Arginine Deficiency on Lymphoma Cells , 1974, British Journal of Cancer.

[23]  L. Jacoby.  Adaptation of cultured human lymphoblasts to growth in citrulline. , 1974, Experimental cell research.

[24]  W. Adler,et al.  Effect of Arginine Deficiency on Synthesis of DNA and Immunoglobulin Receptor of Burkitt Lymphoma Cells , 1970, Nature.

[25]  Guoyao Wu,et al.  Citrulline can preserve proliferation and prevent the loss of CD3 zeta chain under conditions of low arginine. , 2004, JPEN. Journal of parenteral and enteral nutrition.

[26]  A. Meijer,et al.  The phosphatidylinositol 3-kinase inhibitors wortmannin and LY294002 inhibit autophagy in isolated rat hepatocytes. , 1997, European journal of biochemistry.

[27]  K. Sugimura,et al.  Elevated gene expression of argininosuccinate synthetase in peripheral lymphocytes from systemic lupus erythematosus (SLE) patients. , 1992, Autoimmunity.